News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Matrix metalloproteinases reduce beta-2-adrenergic receptor density and cause spontaneous hypertension
Area: Cardiovascular
Enhanced matrix metalloproteinase (MMP) activity has been observed in spontaneously hypertensive rats (SHR). A recent study reports, that MMPs may contribute to the reduced density of the extracellular domain of beta-2-AR in blood vessels and to the increased arteriolar tone of SHRs compared with normotensive rats. The study utilized this anti-beta-2-AR antibody that recognizes the N-terminal region of the protein and can be used for ELISA and western blotting.
The beta-2-adrenergic receptor (AR) is a member of the G protein-coupled receptor superfamily. Different polymorphic forms, point mutations, or alterations in the expression regulation of this gene are associated with nocturnal asthma, obesity and type 2 diabetes.
More »beta-2-adrenergic receptor (AR) antibodies
The published study can be found here:
More »beta-2-adrenergic receptor (AR) antibodies
The published study can be found here:
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011


